NovoCure Limited (NVCR)

NovoCure Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,980	1,595	7,698	7,795	17,615	8,340
Market Cap Growth	-73.61%	-79.27%	-1.24%	-55.75%	111.21%	167.82%
Enterprise Value	1,702	1,279	7,312	7,431	17,205	8,175
PE Ratio	-	-7.71	-83.19	-133.58	889.29	-1153.54
PS Ratio	3.77	3.13	14.31	14.57	35.63	23.74
PB Ratio	5.51	4.40	17.45	18.99	36.97	38.29
P/FCF Ratio	-13.84	-15.89	816.34	133.05	209.25	516.89
P/OCF Ratio	-18.98	-21.76	250.04	94.19	177.66	313.30
EV/Sales Ratio	3.24	2.51	13.60	13.89	34.80	23.27
EV/EBITDA Ratio	-6.87	-5.77	-92.68	-218.05	435.01	1083.42
EV/EBIT Ratio	-6.52	-5.49	-81.68	-167.63	565.94	-8944.70
EV/FCF Ratio	-11.53	-12.74	775.44	126.85	204.38	506.69
Debt / Equity Ratio	1.66	1.64	1.32	1.40	0.93	0.75
Debt / EBITDA Ratio	-2.93	-2.69	-7.41	-16.88	11.23	21.68
Debt / FCF Ratio	-4.92	-5.94	61.96	9.82	5.28	10.14
Quick Ratio	5.99	5.56	6.82	7.36	8.56	4.82
Current Ratio	6.26	5.78	7.00	7.53	8.80	5.10
Asset Turnover	0.46	0.44	0.46	0.48	0.79	0.83
Interest Coverage	-	-	-	-5.73	2.47	-0.12
Return on Equity (ROE)	-50.30%	-51.60%	-21.00%	-14.70%	6.10%	-4.20%
Return on Assets (ROA)	-16.90%	-17.90%	-7.90%	-5.30%	3.20%	-1.70%
Return on Capital (ROIC)	-22.43%	-24.29%	-8.73%	-4.50%	3.61%	-0.24%
Earnings Yield	-9.73%	-12.98%	-1.20%	-0.75%	0.11%	-0.09%
FCF Yield	-6.11%	-6.29%	0.12%	0.75%	0.48%	0.19%
Buyback Yield / Dilution	-1.51%	-1.65%	-1.19%	5.00%	-11.97%	-5.89%
Total Shareholder Return	-1.51%	-1.65%	-1.19%	5.00%	-11.97%	-5.89%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).